Obstetrics & Gynecology · Orland Park, IL
NPI
1346403821
Since 2008
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
15300 West Ave, Suite 120
Orland Park, IL, 60462
Phone (708) 590-5304
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,323
92 services
Medicare patients, 2024
58
Average age 70
Drug cost, 2024
$4,568
116 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan J Dejong was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 31 times for 31 patients. In total Megan J Dejong billed 92 services in 19 codes, and Medicare paid $6,323.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 31 | 31 | $42.99 | $1,333 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 16 | 16 | $46.57 | $745 |
| 99214 Office E&M - Established | Office | 14 | 12 | $102.02 | $1,428 |
By year: 2022 $9,090 for 126 services; 2023 $8,658 for 94 services; 2024 $6,323 for 92 services.
Medicare prescription drug claims, 2024
In 2024, the drug Megan J Dejong prescribed most often to Medicare patients was Sprintec (Norgestimate-Ethinyl Estradiol), with 22 prescriptions and refills. In total Megan J Dejong wrote 116 Medicare prescriptions that cost $4,568.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sprintec Norgestimate-Ethinyl Estradiol | 22 | 22 | Under 11 | $557 |
| Clobetasol Propionate Generic | 20 | 20 | Under 11 | $433 |
Brand drugs: - claims; generic drugs: 107 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Megan J Dejong were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.